FDA Inspection 1316132 — Cogent Biosciences, Inc.
The FDA completed an inspection of Cogent Biosciences, Inc. on Apr 24, 2026 in Waltham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Waltham, MA (United States)
Additional Details
Sponsor, Contract Research Organization